Sanjivani Paranteral achieves robust Q2 FY25 growth with 29.5% revenue surge
Sanjivani Paranteral Ltd, a pharmaceutical powerhouse based in Mumbai, has announced remarkable financial results for Q2 of the fiscal year 2025, showcasing significant growth across ... Read More
Sanjivani Paranteral reports 58% growth in Q4 FY24 revenue at Rs 128.64 million
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai and Dehradun, has announced impressive financial results ... Read More